
Moderna, Inc.
USD49.06
+3.42 (+7.49%)
CEO
Stéphane Bancel
IPO Date
2018-12-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$45.30
Prev. Close
$45.64
Day Low
$45.30
Day High
$49.55
52W Low
$22.28
52W High
$59.55
Market Cap
$19.47B
Volume
6.75M
| -4.5 |
| 31 Dec 2023 | FY | 31.5% | -68.8% | -34.0% | -25.6% | 0.09 | 3.42 | -8.1 |
| 31 Dec 2022 | FY | 71.9% | 43.4% | 43.7% | 32.3% | 0.06 | 2.73 | 8.9 |
| 31 Dec 2021 | FY | 85.2% | 68.8% | 86.3% | 49.5% | 0.06 | 1.92 | 8.4 |
| 31 Dec 2020 | FY | 97.1% | -272.2% | -29.2% | -10.2% | 0.26 | 1.43 | -53.3 |
| 31 Dec 2019 | FY | 100.0% | -1070.1% | -43.8% | -32.3% | 0.17 | 8.82 | -12.6 |
| 31 Dec 2018 | FY | 110.2% | -314.0% | -25.1% | -19.6% | 0.07 | 7.02 | -3.2 |
| 31 Dec 2017 | FY | 100.0% | -144.6% | -40.9% | -23.6% | 0.14 | 4.09 | -27.3 |
| 31 Dec 2016 | FY | 100.0% | -212.9% | -25.7% | -15.3% | 0.04 | 6.68 | -32.3 |
| -12.6 |
| 30 Jun 2025 | Q2 | 16.2% | -581.0% | -8.8% | -6.9% | 0.08 | 3.93 | -3.2 |
| 31 Mar 2025 | Q1 | 15.9% | -907.5% | -9.6% | -7.6% | 0.07 | 4.22 | -2.8 |
| 31 Dec 2024 | Q4 | 22.7% | -117.2% | -10.3% | -7.9% | 0.07 | 3.67 | -3.6 |
| 30 Sept 2024 | Q3 | 72.3% | 0.7% | 0.1% | 0.1% | 0.11 | 4.39 | 494.8 |
| 30 Jun 2024 | Q2 | 35.3% | -530.7% | -10.9% | -8.2% | 0.05 | 4.09 | -8.7 |
| 31 Mar 2024 | Q1 | 21.0% | -703.6% | -9.2% | -7.0% | 0.10 | 4.03 | -8.6 |
| 31 Dec 2023 | Q4 | 67.0% | 7.7% | 1.6% | 1.2% | 0.09 | 3.42 | 43.7 |
| 30 Sept 2023 | Q3 | -22.4% | -198.3% | -27.0% | -18.7% | 0.10 | 2.46 | -2.7 |